Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

NCT ID: NCT00355589

Last Updated: 2012-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Blood Pressure, High

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hypertension High Blood Pressure Diuretic Angiotensin converting enzyme inhibitor Ambulatory blood pressure monitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ramipril and hydrochlorothiazide

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Previously diagnosed, or newly diagnosed essential hypertension. Blood pressure must be within a minimum and maximum range prior to drug treatment.

Exclusion Criteria

* Inability to discontinue all prior antihypertensive medications
* Heart failure
* History of stroke, myocardial infarction, or chest pain within 3 years, or an abnormal heart rhythm
* Liver or kidney disease
* Certain drugs used to treat other conditions like an enlarged prostate gland, or arthritis
* Allergy or reactions to certain medications used to treat high blood pressure
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cahaba Research Inc.

Birmingham, Alabama, United States

Site Status

Clinical Research Associates

Huntsville, Alabama, United States

Site Status

Pulmonary Associates

Glendale, Arizona, United States

Site Status

Impact Clinical Trials

Beverly Hills, California, United States

Site Status

Lovelace Scientific Resources, Inc.

Beverly Hills, California, United States

Site Status

Associated Pharmaceutical Research Center, Inc.

Buena Park, California, United States

Site Status

Marin Endocrine Care and Research

Greenbrae, California, United States

Site Status

Memorial Research Medical Clinic

Long Beach, California, United States

Site Status

The Intermed Group; Samaritan Medical Tower

Los Angeles, California, United States

Site Status

National Research Institute

Los Angeles, California, United States

Site Status

Clinical Trials Research

Roseville, California, United States

Site Status

Bayview Research Group

Studio City, California, United States

Site Status

Viking Clinical Research

Temecula, California, United States

Site Status

University of Connecticut Health Center

Farmington, Connecticut, United States

Site Status

Clinical Research of West Florida, Inc.

Clearwater, Florida, United States

Site Status

Clinical Research of South Florida

Coral Gables, Florida, United States

Site Status

University Clinical Research Deland, Inc.

DeLand, Florida, United States

Site Status

South Florida Clinical Research Center

Hollywood, Florida, United States

Site Status

Innovative Research of West Florida

Largo, Florida, United States

Site Status

International Research Associates, LLC

Miami, Florida, United States

Site Status

Lifespan Research Foundation

Miami, Florida, United States

Site Status

Sun Coast Clinical Research

New Port Richey, Florida, United States

Site Status

Renstar Medical Research

Ocala, Florida, United States

Site Status

Suncoast Clinical Research, Inc.

Palm Harbor, Florida, United States

Site Status

University Clinical Research, Inc.

Pembroke Pines, Florida, United States

Site Status

Lovelace Scientific Resources

Sarasota, Florida, United States

Site Status

Metabolic Research Institute, Inc.

West Palm Beach, Florida, United States

Site Status

Executive Health and Research Associates, Inc.

Atlanta, Georgia, United States

Site Status

Cedar Crosse Research Center

Chicago, Illinois, United States

Site Status

James R. Herron, MD, Ltd.

Chicago, Illinois, United States

Site Status

Clinical Investigation Specialists, Inc.

Gurnee, Illinois, United States

Site Status

Midwest Institute for Clinical Research

Indianapolis, Indiana, United States

Site Status

Michigan Institute of Medicine

Livonia, Michigan, United States

Site Status

Medical Research Associates

Traverse City, Michigan, United States

Site Status

Twin Cities Clinical Research

Brooklyn Center, Minnesota, United States

Site Status

Advanced Biomedical Research of America

Las Vegas, Nevada, United States

Site Status

Partners in Primary Care

Voorhees Township, New Jersey, United States

Site Status

Cumberland Research Assocites, LLC

Fayetteville, North Carolina, United States

Site Status

Unifour Medical Research Associates

Hickory, North Carolina, United States

Site Status

Triangle Medical Research Associates

Raleigh, North Carolina, United States

Site Status

The Lipid Center

Statesville, North Carolina, United States

Site Status

Lyndhurst Gynecologic Associates, PA

Winston-Salem, North Carolina, United States

Site Status

Piedmont Medical Research Associates

Winston-Salem, North Carolina, United States

Site Status

Sterling Research Group, Inc.

Cincinnati, Ohio, United States

Site Status

Smith Clinical Research

Marion, Ohio, United States

Site Status

Radiant Research - Mogadore

Mogadore, Ohio, United States

Site Status

Lion Research

Norman, Oklahoma, United States

Site Status

Medford Medical Clinic Research Dept.

Medford, Oregon, United States

Site Status

Philadelphia Health Associates

Philadelphia, Pennsylvania, United States

Site Status

Medical Research South

Charleston, South Carolina, United States

Site Status

SC Clinical Research Center, LLC

Columbia, South Carolina, United States

Site Status

Radiant Research - Greer

Greer, South Carolina, United States

Site Status

MetaClin Research, Inc.

Austin, Texas, United States

Site Status

Punzi Medical Center

Carrollton, Texas, United States

Site Status

Research Across America

Dallas, Texas, United States

Site Status

Radiant Research - San Antonio

San Antonio, Texas, United States

Site Status

WellMed Medical Management

San Antonio, Texas, United States

Site Status

Clinical Research Associates of Tidewater

Norfolk, Virginia, United States

Site Status

The Chase Wellness Center, Inc

Virginia Beach, Virginia, United States

Site Status

Radiant Research - Tacoma

Lakewood, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

White WB, Cleveland JM, Rolleri RL; Ramipril-Hydrochlorothiazide Study Group. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial. J Hum Hypertens. 2008 Aug;22(8):559-68. doi: 10.1038/jhh.2008.26. Epub 2008 May 8.

Reference Type DERIVED
PMID: 18463672 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B5051001

Identifier Type: OTHER

Identifier Source: secondary_id

K749-06-3001

Identifier Type: -

Identifier Source: org_study_id